EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight

GO MOMs Study Group*

Diabetes Care · 2026

DOI: 10.2337/dc26-0302 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes Care, 2026. Verfasst von GO MOMs Study Group*. Hauptthemen laut MEDLINE: Diabetes, Gestational, Birth Weight. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE We evaluated whether early pregnancy oral glucose tolerance testing (OGTT) or continuous glucose monitoring (CGM) improves gestational diabetes mellitus (GDM) or large-for-gestational-age (LGA) birth prediction over clinical factors alone. RESEARCH DESIGN AND METHODS In the Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs) study, a prospective observational study at nine U.S. sites (2021–2025), participants with singleton gestation and without preexisting diabetes underwent blinded 75-g OGTT and CGM at 10–14 weeks’ gestation. Predictive models for GDM at 24–28 weeks and LGA were developed using these data and clinical factors (maternal age, BMI, GDM or macrosomia history). New glycemic criteria maximized the area under the receiver operating characteristic curve in training data from four sites and were validated in five. Models incorporating OGTT or CGM criteria versus clinical factors alone compared positive predictive value (PPV) at a prespecified negative predictive value (NPV) at a reported 8.3% national GDM prevalence and 10% for LGA. RESULTS Of 2,178 participants, 93.3% who were pregnant at 24–28 weeks completed OGTTs (15.4% GDM), and 98.1% with live births had data to determine LGA (11.2% LGA). At NPV ≥96% and 8.3% GDM prevalence, PPV for GDM was 12.2% (95% CI 11.0–13.3%) for clinical factors alone, 26.5% (23.1–30.3%) for OGTT plus clinical factors, and 19.8% (17.2–22.5%) for CGM plus clinical factors. For LGA, neither glycemic model improved PPV. Validation confirmed findings. CONCLUSIONS In a U.S.-representative population, adding 10- to 14-week OGTT or CGM criteria to clinical factors improved GDM but not LGA prediction. Future studies should determine whether predicting GDM in the first trimester facilitates interventions that improve GDM-related pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalBirth WeightHumansFemalePregnancyInfant, Large for Gestational AgeGlucose Tolerance TestAdultContinuous Glucose MonitoringBlood GlucoseProspective StudiesInfant, Newborn

Substanzen

Blood Glucose

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

GO MOMs Study Group* (2026). Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight. Diabetes Care. https://doi.org/10.2337/dc26-0302

Vancouver

GO MOMs Study Group*. Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight. Diabetes Care. 2026. doi:10.2337/dc26-0302

BibTeX
@article{GOMOMsStudyGroup2026,
  author = {GO MOMs Study Group*, GO MOMs Study Group*},
  title = {Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-0302}
}
Kostenlos starten →